Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
Category - Pharmaceuticals
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...
Lilly Phase 3 trial shows oral GLP-1 maintains weight loss after...
Eli Lilly has reported Phase 3 results showing that its investigational oral GLP-1 therapy...
Sanofi to acquire Dynavax, expanding adult vaccine portfolio
Sanofi has agreed to acquire Dynavax Technologies Corporation, adding an approved adult hepatitis B...
GSK Announces Promising Blood Cancer Data at ASH 2025 –...
GSK is set to present new data from its haematology portfolio at the American Society of Hematology...
Domino Data Lab Launches Automated Quality Control for Clinical...
Domino Data Lab has introduced Domino SCE QC, a new capability designed to automate and streamline...
Clinigen to Acquire SSI Strategy, Strengthening Biotech...
Clinigen, a global leader in accelerating patient access to critical medicines, has announced a...
Hikma and Celltrion deepen biosimilar partnership to broaden...
Hikma Pharmaceuticals PLC and Celltrion Healthcare Co., Ltd. have announced a new phase in their...
US-UK Tech Pact to Accelerate Drug Discovery & Create Jobs
The United Kingdom and United States have formalised a Tech Prosperity Deal aimed at speeding up...
New 36-Month Efficacy and Safety Data for Leqembi (Lecanemab)...
Eisai has announced new 36-month (3-year) efficacy and safety results from its Phase 3 Clarity AD...